News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
882,659 Results
Type
Article (88711)
Company Profile (816)
Press Release (793109)
Multimedia
Podcasts (234)
Webinars (35)
Section
Business (233558)
Career Advice (4161)
Deals (39971)
Drug Delivery (176)
Drug Development (91673)
Employer Resources (207)
FDA (18546)
Job Trends (17481)
News (398661)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3051)
Academic (2)
Accelerated approval (54)
Adcomms (40)
Allergies (189)
Alliances (56988)
ALS (228)
Alzheimer's disease (1957)
Antibody-drug conjugate (ADC) (534)
Approvals (18867)
Artificial intelligence (844)
Autoimmune disease (343)
Automation (62)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (242)
Biotechnology (480)
Bladder cancer (210)
Brain cancer (84)
Breast cancer (823)
Cancer (6443)
Cardiovascular disease (546)
Career advice (3595)
Career pathing (51)
CAR-T (372)
CDC (76)
Celiac Disease (3)
Cell therapy (1047)
Cervical cancer (51)
Clinical research (78778)
Collaboration (2316)
Company closure (8)
Compensation (1467)
Complete response letters (103)
COVID-19 (3038)
CRISPR (122)
C-suite (1248)
Cystic fibrosis (166)
Data (8458)
Decentralized trials (3)
Denatured (89)
Depression (190)
Dermatology (94)
Diabetes (653)
Diagnostics (7558)
Digital health (64)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (414)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (312)
Earnings (102462)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138283)
Executive appointments (1178)
FDA (22532)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1894)
Gene editing (268)
Generative AI (87)
Gene therapy (842)
GLP-1 (1260)
Government (5554)
Grass and pollen (8)
Guidances (417)
Healthcare (21212)
HIV (91)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (108)
Immunology and inflammation (351)
Immuno-oncology (112)
Indications (199)
Infectious disease (3428)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (309)
Interviews (820)
IPO (17996)
IRA (61)
Job creations (5207)
Job search strategy (2871)
JPM (73)
Kidney cancer (22)
Labor market (118)
Layoffs (684)
Leadership (52)
Legal (10171)
Liver cancer (110)
Longevity (36)
Lung cancer (857)
Lymphoma (453)
Machine learning (65)
Management (66)
Manufacturing (1190)
MASH (220)
Medical device (15255)
Medtech (15394)
Mergers & acquisitions (23253)
Metabolic disorders (1747)
mRNA (261)
Multiple sclerosis (203)
NASH (24)
Neurodegenerative disease (492)
Neuropsychiatric disorders (126)
Neuroscience (3659)
Neurotech (2)
NextGen: Class of 2026 (7714)
Non-profit (5140)
Now hiring (80)
Obesity (840)
Opinion (371)
Ovarian cancer (240)
Pain (281)
Pancreatic cancer (335)
Parkinson's disease (406)
Partnered (39)
Patents (640)
Patient recruitment (727)
Peanut (67)
People (67880)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24347)
Phase 2 (34217)
Phase 3 (25734)
Pipeline (9424)
Policy (394)
Postmarket research (3559)
Preclinical (10950)
Press Release (72)
Prostate cancer (339)
Psychedelics (68)
Radiopharmaceuticals (367)
Rare diseases (1228)
Real estate (7461)
Recruiting (81)
Regulatory (30265)
Reports (77)
Research institute (2768)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (28)
RSV (98)
Schizophrenia (194)
Series A (318)
Series B (229)
Service/supplier (28)
Sickle cell disease (122)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4368)
State (2)
Stomach cancer (21)
Supply chain (143)
Tariffs (104)
The Weekly (142)
Vaccines (1295)
Venture capital (128)
Weight loss (577)
Women's health (136)
Worklife (24)
Date
Today (188)
Last 7 days (796)
Last 30 days (3488)
Last 365 days (33088)
2026 (15018)
2025 (33222)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (395)
Arkansas (16)
Asia (52215)
Australia (9179)
California (14144)
Canada (3967)
China (1527)
Colorado (606)
Connecticut (628)
Delaware (434)
Europe (120381)
Florida (2096)
Georgia (461)
Hawaii (4)
Idaho (70)
Illinois (1222)
India (101)
Indiana (655)
Iowa (25)
Japan (575)
Kansas (142)
Kentucky (56)
Louisiana (50)
Maine (89)
Maryland (1722)
Massachusetts (10327)
Michigan (421)
Minnesota (786)
Mississippi (7)
Missouri (162)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3752)
New Mexico (34)
New York (3715)
North Carolina (1910)
North Dakota (11)
Northern California (7027)
Ohio (438)
Oklahoma (26)
Oregon (55)
Pennsylvania (2801)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5529)
Tennessee (223)
Texas (2295)
United States (50601)
Utah (422)
Vermont (1)
Virginia (357)
Washington D.C. (89)
Washington State (1163)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 882,659 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Defence Therapeutics Appoints Antibody Drug Conjugates Pioneer Dr. John Lambert to Its Board of Directors
June 1, 2026
·
6 min read
Press Releases
Hiteck’s Aponermin for Injection Showcases Preliminary Clinical Data at ASCO 2026
June 1, 2026
·
1 min read
Press Releases
Gaelic Labs gains BSI Kitemark™ Certification for Minimized Risk of AMR
Gaelic Laboratories, a GMP-approved manufacturer of Beta-Lactam antibiotics, has successfully obtained BSI Kitemark™ Certification for Minimized Risk of Antimicrobial Resistance (AMR), demonstrating a commitment to responsible manufacturing.
June 1, 2026
·
1 min read
Press Releases
Radioligand Therapy (RLT) Market Worth $10.91 Billion by 2035, Growing at 13.2% CAGR
June 1, 2026
·
1 min read
Press Releases
Ainnocence Proposes a Seven-Rule Governance Framework and Value Scorecard for AI-Driven Drug Discovery
CEO and Founder Dr. Lurong Pan calls on the AI pharmaceutical industry to set boundaries for the algorithm, pairing executable safety rules with an honest, two-dimensional method for measuring what a model actually contributes
June 1, 2026
·
1 min read
Cancer
ASCO: A battle of bispecifics, Eli Lilly’s big win and more
Practice-changing data in lung cancer, prostate cancer and more were on display over the weekend at the American Society of Clinical Oncology annual meeting in Chicago. Plus, early readouts on assets that could reshape the cancer landscape.
June 1, 2026
·
4 min read
·
Brianna Abbott
Press Releases
Lynk Pharmaceuticals Announces NMPA Approval of LNK01004 Ointment’s Phase II Clinical Trial for the Treatment of Vitiligo and Chronic Hand Eczema
June 1, 2026
·
4 min read
Press Releases
Phenomenex Launches Endrix Long Life Columns, Redefining Column Durability and Method Reliability
June 1, 2026
·
3 min read
Press Releases
Wockhardt Receives U.S. FDA Approval for ZAYNICH™ (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis
June 1, 2026
·
10 min read
Press Releases
Iterion Therapeutics Reports First Clinical Validation of Tegavivint as a Targeted Therapy for Wnt-Driven Advanced HCC in Oral Presentation at 2026 ASCO Annual Meeting
June 1, 2026
·
5 min read
1 of 88,266
Next
